smartbax
About:
smartbax develop novel multi-targeted, antibacterial compounds with extraordinary potency against multi-drug resistant bacteria.
Website: https://www.smartbax.de
Top Investors: Boehringer Ingelheim Venture Fund, HTGF | High-Tech Gruenderfonds
Description:
smartbax develop novel multi-targeted, antibacterial compounds with extraordinary potency against multi-drug resistant bacteria and difficult-to-treat biofilms.
Total Funding Amount:
1.9M EUR
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
Munich, Bayern, Germany
Founded Date:
2021-01-01
Contact Email:
info(AT)smartbax.de
Founders:
Number of Employees:
1-10
Last Funding Date:
2023-05-23
IPO Status:
Private
Industries:
© 2025 bioDAO.ai